SHARON BARKER: Open Payments
NPI 1447223110 · TACOMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,038 in 139 payments from 18 companies in 2025. Trend: 2023 $740 · 2024 $2,567 · 2025 $4,038
Food & beverage: $3,984Education: $54
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $1,102 |
| Janssen Biotech, Inc. | 27 | $908 |
| Phathom Pharmaceuticals, Inc. | 16 | $525 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $364 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $171 |
| Lilly USA, LLC | 3 | $169 |
| QOL Medical, LLC | 5 | $153 |
| PFIZER INC. | 13 | $141 |
| CONMED Corporation | 1 | $108 |
| Regeneron Healthcare Solutions, Inc. | 3 | $77 |
Products named: TREMFYA, VOQUEZNA, LINZESS, SKYRIZI, RINVOQ, ENTYVIO, XIFAXAN, EOHILIA.
Industry payments across WA — which companies pay providers there.
